The anti-doping code in sport - update for 2004
- Aust Prescr 2004;27:84-7
- 1 August 2004
- DOI: 10.18773/austprescr.2004.072
The World Anti-Doping Agency has assumed responsibility for international doping control from the International Olympic Committee. It has revised, reformed and now presented a new World Anti-Doping Code, which became globally effective in January 2004. The World Anti-Doping Code contains the List of Prohibited Substances and Prohibited Methods. This list differs from its predecessor. Caffeine has been removed from the banned list, but a new category of 'specified substances' which may produce inadvertent positive tests has been added.
Over recent years, the World Anti-Doping Agency (WADA)* has worked with the International Olympic Committee (through its member national organisations) to produce a new World Anti-Doping Code (WADC).1 This replaces previous lists of prohibited substances and methods.2 The new Code has a number of implications for athletes, coaches and medical practitioners. Athletes are responsible for making sure that medications they take comply with the Code.
The rationale for determining whether or not a substance should be placed on the prohibited list is based on three criteria:
If two of these criteria are met, the substance is considered for inclusion on the prohibited list (see Box 1).
Examples of prohibited substances
Stimulants (but pseudoephedrine and caffeine have been removed from the list)
Agents with anti-oestrogenic activity
Of recent notoriety is tetrahydrogestrinone, a synthetic derivative, which has produced a number of positive doping tests among sprint and power athletes. Tetrahydrogestrinone was apparently provided to athletes as a supplement, and bears a similar history in this respect to nandrolone, which has often been identified in positive urine samples.
A positive doping test for testosterone still depends upon finding a urinary testosterone/epitestosterone ratio greater than six. Should an endogenous anabolic steroid be found in such a circumstance, further investigation is obligatory in order to determine whether the ratio is due to a physiological or pathological condition.
Other anabolic agents on the prohibited list include the beta agonists clenbuterol and zeranol.
The following peptide hormones are all prohibited, as are their mimetics and releasing factors (releasing hormones):
All beta agonists (including their D-and L-isomers) are prohibited except:
The exempted drugs are only permitted by inhalation to prevent and/or treat asthma and exercise-induced bronchoconstriction. A medical notification is required for the athlete to compete. If the concentration of salbutamol in urine exceeds 1000 ng/mL, it will be considered an adverse analytical finding unless the athlete proves that the abnormal result was the consequence of the therapeutic use of inhaled salbutamol.
These agents can conceal the use of other substances and include diuretics, epitestosterone, probenecid and the plasma expanders, such as dextran and hydroxyethyl starch (see Box 2).
Diuretics - promote excretion of urine
Epitestosterone - used to correct an altered testosterone/ epitestosterone ratio
Probenecid - blocks excretion of anabolic agents
Plasma expanders - alter red cell parameters such as haemoglobin and haematocrit (used in the detection of erythropoietin abuse)
Corticosteroids are prohibited when given orally, rectally or by intravenous or intramuscular administration. A medical notification is necessary for all topical applications, inhalational use, or intralesional or intra-articular injection.
The criteria for determining if a method of doping should be banned are the same as those for determining prohibited substances.
This includes blood doping and the use of products that enhance the uptake, transport and delivery of oxygen. Examples include erythropoietin, modified haemoglobin products, perfluorochemicals, and efaproxiral (RSR13).
These techniques are intended to alter the integrity and validity of specimens collected in doping control tests. They include catheterisation of the bladder, urine substitution and/or tampering, inhibition of renal excretion and alterations of testosterone and epitestosterone concentrations.
This is defined as the non-therapeutic use of genes, genetic elements and/or cells that have the capacity to enhance athletic performance. (The Code anticipates the possible future use of genetic engineering in sport.)
Under the new WADA Code, particular sports have identified particular substances they wish to prohibit only during competition periods. These substances include:
The prohibited list identifies substances which are particularly susceptible to unintentional violations of anti-doping rules because of their general availability in medicinal products, or because they are less likely to be successfully abused as doping agents. Consequently, a doping violation involving these specified substances may result in a reduced sanction (penalty) as noted in the WADA Code, provided the 'athlete can establish that the use of such a specified substance was not intended to enhance sport performance'.
Specified substances are:
One major change from the previous regulations is the removal of caffeine from the banned list. A review of caffeine has deemed it to be performance enhancing at concentrations lower than those required to produce a positive test (urinary levels of 12 mg/L).3
As caffeine is widely available in a variety of foods and drinks it is easily used as a performance enhancing agent. Although caffeine will be monitored at competitions through urine testing, no action will be taken against athletes who show caffeine in their urine.
Medical notification relates to the use of substances which are not on the banned list, but are permitted for use under certain specified conditions. Notifiable substances are the beta agonists, formoterol, salbutamol, salmeterol and terbutaline, which are permitted for the treatment of asthma and exercise-induced bronchospasm.
Notification must be made by a medical practitioner on the athlete's behalf specifying the substance, the dosage, duration of treatment, and the diagnosis of asthma or exercise-induced bronchospasm. The athlete's national sporting organisation is to be notified well in advance of any competition (where the athlete may be tested by doping control). The onus is on the athlete to ensure that documentation is appropriate and timely.
Authorities should also be notified about the use of glucocorticosteroids when used by inhalation (for the treatment of asthma and/or allergic rhinitis), by injection (into joints, bursae or lesions - but not intravenously or by intramuscular injection), or as topical applications in the ear, the eye or on the skin. Notification is the responsibility of the athlete, and the sporting organisation must be notified of the details of the diagnosis, substance used, dosage, and duration of treatment.
While medical notification is for substances permitted under certain conditions, therapeutic use exemption is for the therapeutic use of a substance or method which is on the prohibited list. In Australia, the Australian Sports Drug Medical Advisory Committee (ASDMAC) is the body which grants exemptions.
Should an athlete require treatment with a prohibited substance or prohibited method, a medical practitioner may apply to ASDMAC by way of its web site or by mail for a therapeutic use exemption (see Further information).The ASDMAC form specifies the relevant details which need to be provided - including athlete details, the medical condition(s) (with supporting evidence), treatment(s) being recommended (with dosages and duration of treatment) and other details as necessary. The decision to grant an exemption depends upon:
In addition, the need for use of the substance or method cannot be a consequence in any way of prior non-therapeutic use of any prohibited substance or method.
In medical emergencies, such as hospital admission, whereby a prohibited substance or method is used appropriately, a therapeutic use exemption can be provided after the event. An application should be made as quickly as possible.
At first pass the WADA Code appears complex and somewhat confusing. However, the Code attempts to limit the opportunity to cheat by specifying prohibited substances in and out of competition, while allowing for the use of substances under certain conditions (notifiable substances), the use of banned substances for therapeutic purposes, and the recognition that some substances may produce inadvertent positive dope tests while not being used for performance enhancement (specified substances). It should also be recognised that many nutritional supplements contain banned substances and extreme caution should be taken to avoid inadvertent doping.
Finally, the concerns about drugs in sport and doping are not confined to young elite athletes - similar concerns should be held for any athlete who wishes to compete at any age.
World Anti-Doping Agency http://www.wada-ama.org
The World Anti-Doping Code http://www.wada-ama.org/docs/web/standards_harmonization/code/code_v3.pdf
The 2004 Prohibited list http://www.wada-ama.org/docs/web/standards_harmonization/code/list_standard_2004.pdf
Australian Sports Drug Medical Advisory Committee (ASDMAC) - for Applications for therapeutic use exemption
PO Box 345
CURTIN ACT 2605
Fax: (02) 6206 0262
Australian Sports Drug Agency (ASDA) Drugs in Sport Hotline
- a confidential, free call service for athletes and their support staff that offers information on the status of Australian pharmaceutical medications and substances in sport Phone: 1800 020 506
Conflict of interest: none declared
The following statements are either true or false.
1. Caffeine is a prohibited substance in elite sports.
2. The prescription of a topical corticosteroid should be notified to an athlete's sporting organisation.
Answers to self-help questions1. False